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Background: The longitudinal birth cohort study is the preferred design for studies of childhood health, particularly
atopic disease. Still, prospective data collection depends on recollection of the medical history since the previous
visit representing a potential recall-bias. We aimed to ascertain the quality of information on atopic disease and
other health symptoms reported by parental interview in a closely monitored birth cohort study. Possible bias from
symptom severity and socioeconomics were sought.
Methods: Copenhagen study on Asthma in Childhood (COPSAC) is a clinical birth cohort study of 411 children
born of asthmatic mothers from 1999 to 2001. Child health is monitored at six-monthly visits with particular
emphasis on atopic symptoms and infections. Data from the first three study years on 260 children was compared
with records from their family practitioner as an external reference.
Results: A total of 6134 medical events were reported at the COPSAC interviews. Additional 586 medical events
were recorded by family practitioners but not reported at the interview. There were no missed events related to
asthma, eczema or allergy. Respiratory, infectious and skin related symptoms showed completeness above 90%,
other diseases showed lower completeness around 77%. There was no meaningful influence from concurrent
asthma or socioeconomics.
Conclusions: The COPSAC study exhibited full sensitivity to the main study objectives, atopic disease, and high
sensitivity to respiratory, infectious and skin related illness. Our findings support the validity of parental interviews in
longitudinal cohort studies investigating atopic disease and illness in childhood.
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InfectionsBackground
The longitudinal birth cohort study is the preferred de-
sign for studies of the origins of chronic diseases in
childhood such as asthma [1,2], partly because recall bias
is minimized. The prospective clinical cohort study with
doctor’s interview and examination at regular visits to
the clinic is expected to have the highest completeness
capturing medical and exposure history. Recall bias is
reduced with a high frequency of visits to the clinic, but
information still depends on recollection of the medical* Correspondence: nadja.vissing@dbac.dk
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reproduction in any medium, provided the orhistory since the previous visit. Particularly short-term
symptoms such as common childhood infections may be
influenced by recall bias [3,4]. Diary data is considered a
valid source and provides strong support to the history
taking at the clinic. But such data collection also
depends on a high level of compliance and the risk of
data being influenced by socioeconomics of the subjects
[4,5].
The validity of information obtained in prospective
clinical cohort studies have been sparsely investigated, in
part because this requires a comparison with an external
standard, which is rarely available [6,7].
The Copenhagen Prospective Study on Asthma in
Childhood (COPSAC) is an ongoing clinical, prospective,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mothers with asthma designed to intensively investigate
the development of atopic diseases in high-risk children,
with a dedicated research clinic providing the families
ready access to clinical evaluation and treatment with
scheduled and acute clinical visits. Any atopic or respira-
tory illness is seen and treated by the research doctors.
Precise case definition of atopic disease is the hallmark
of the COPSAC cohort study. Nevertheless, as dedicated
as the research unit can be, it still requires a high level
of compliance from study participants. Children that are
diagnosed and treated by other physicians without our
knowledge would potentially compromise the quality of
our data.
We aimed to ascertain the completeness of our data
on atopic diseases during the first three years of life in
an ongoing prospective clinical birth cohort study. Sec-
ondly we aimed to investigate potential underreporting
of the history of symptoms, diagnoses and other health
care resource utilization reported by interview at six-
monthly visits at our clinical research unit. Information
collected by the family’s General Practitioner was used
as external reference for such missing data. As a part of
this analysis we tried to look at bias in parent-reporting
related to the child’s asthma status and socioeconomics
of the family.Methods
Study cohort
COPSAC is a longitudinal birth cohort study designed
to examine the relation between the genetics, environ-
mental and lifestyle factors and development of asthma,
eczema and allergic symptoms in early life. The cohort
study design and characteristics have previously been
described in detail [8].
Subjects participating in COPSAC were recruited be-
tween August 1998 and December 2001 among pregnant
mothers with a history of asthma diagnosed by a doctor
and requiring medication. 411 children of asthmatic
mothers were included in a comprehensive program of
clinical and objective assessments. At three years of age
350 children (85%) were still active in the cohort. Chil-
dren attended the COPSAC clinic for planned visits at
one month of age and every six months. Additionally
they were seen for any acute airway and/or skin symp-
toms. At each six-monthly visit, the medical doctors at
COPSAC interviewed the parents about any illnesses,
symptoms and use of medication during the previous six
months. The doctor assessed the reported illnesses, ask-
ing clarifying questions when needed, and classified
them as ‘medical events’ by ICD10 codes. Medical events
were entered online into the COPSAC database with a
start and end date for each episode of illness. If a childwas seen during a medical event, the end date was added
at the following interview session.
All data were collected according to Good Clinical
Practice data management and quality control proce-
dures including external monitoring. The study is con-
ducted in accordance with the Declaration of Helsinki
and approved by the Copenhagen Ethics Committee
(KF01-289/96) and the Danish Data Protection Agency
(2008-41-1754). Written informed consent was obtained
from both parents/legal guardians.Disease categories
In the present analysis we classified all diagnoses into
the following five groups: 1. Atopic diseases (asthma,
atopic dermatitis and allergic rhinitis), 2. Airway related
illness (upper and lower airway infections), 3. Skin
related illness (all diagnoses related to skin other than
atopic dermatitis), 4. Childhood infections (infections
with fever, without airway symptoms) and 5. Other ill-
ness. For group details see Table 1.Atopic disease
Asthma
Since the study population comprised children below 3
years of age the diagnosis of asthma was based largely
on symptoms, according to international guidelines [9].
Diagnosis of asthma was based on a predefined algo-
rithm [9,10] focusing on persistent wheezy symptoms
and subsequent response to treatment. Respiratory
symptoms were recorded by the parents in daily diaries.
The description of symptoms was supported by a book
(written for parents, about early childhood wheeze) that
was integrated with the diary cards. The COPSAC doc-
tors reviewed the diary entries with the parents at the 6
monthly visits as well as during acute episodes of
wheeze. A wheezy episode was defined on the diary card
as 3 consecutive days of wheeze. Persistent wheeze was
defined as five such episodes within 6 months or daily
symptoms for 4 consecutive weeks leading to a 3-month
course of inhaled corticosteroids (ICS). Acute severe
asthmatic exacerbation also led to a 3-month course of
ICS. Children responding to treatment and with a re-
lapse when stopping treatment were diagnosed with
asthma. Further treatment followed a strict algorithm
previously described in details [11,12].
Atopic dermatitis was defined by the criteria of
Hanifin and Rajka based on the presence of 3 of 4
major criteria and at least 3 of 23 minor signs as pre-
viously detailed [13].
Allergic rhinitis was diagnosed in children with sea-
sonal symptoms and sensitization to relevant allergens
measured by a specific IgE test [14]. Symptoms were
defined as persistent troublesome sneezing or blocked or
Table 1 Frequencies and completeness of diagnoses in groups
COPSAC (n) Missed events Total (N) Completeness (n/N)
Atopic disease (Ever) 172 0 172 1.00
Asthma 48 0 48 1.00 [0.94, 1.00]*
Atopic dermatitis 113 0 113 1.00 [0.97, 1.00]*
Allergic rhinitis 11 0 11 1.00 [0.76, 1.00]*
Airway related disease 3104 154 3258 0.95 [0.94, 0.96]**
Common cold 1690 61 1751 0.97
Otitis media 587 44 631 0.93
Pneumonia 264 11 275 0.96
Cough 208 23 231 0.90
Tonsilitis 130 10 140 0.93
Tubulation 106 1 107 0.99
Croup 85 4 89 0.96
RS-virus 33 0 33 1.00
Pertussis 1 0 1 1.00
Skin related disease 878 49 927 0.95 [0.93, 0.96]**
Dermatitis 438 13 451 0.97
Dry skin 166 0 166 1.00
Erythema 96 13 109 0.88
Nappy dermatitis 93 7 100 0.93
Impetigo 41 6 47 0.87
Urticaria 32 8 40 0.80
Herpes infection 12 2 14 0.86
Childhood infections 969 88 1057 0.92 [0.89, 0.94]**
Fever 684 81 765 0.89
Chicken pox 110 1 111 0.99
3-day fever 72 6 78 0.92
Influenza 63 0 63 1.00
Fever cramps 25 0 25 1.00
Erythema infectiosum 8 0 8 1.00
Scarlet fever 7 0 7 1.00
Other illness 1010 295 1305 0.77 [0.74, 0.80]**
Diarrhea and Vomiting 417 62 479 0.87
Conjunctivitis 252 114 366 0.69
Candidiasis 68 31 99 0.69
Constipation 28 10 38 0.74
Minor trauma 18 37 55 0.33
Adenectomy 14 0 14 1.00
Insect bite 11 5 16 0.69
Urinary Tract infection 10 1 11 0.91
Molluscs 9 2 11 0.82
Abscess 6 2 8 0.75
Mononucleosis 3 0 3 1.00
Septicaemia 3 0 3 1.00
Vissing et al. BMC Medical Research Methodology 2012, 12:160 Page 3 of 7
http://www.biomedcentral.com/1471-2288/12/160
Table 1 Frequencies and completeness of diagnoses in groups (Continued)
Burn 2 6 8 0.25
Other, non-infectious events 169 25 194 0.87
Total 6134 586 6719 0.91 [0.90,0.92]**
* Exact one-sided lower 95% confidence interval.
** Two-sided 95% confidence interval.
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in periods without common cold, fever or flu [15].
Parents were requested to contact the COPSAC clinic
if their child developed any kind of airway or skin
related symptoms. If a child developed asthma, eczema
or allergic rhinitis, it attended the clinic every three
months for clinical evaluation and additionally at acute
disease exacerbation. All medical treatment was handled
by the COPSAC clinic.
In the present study atopic diseases were viewed as
life-time diagnoses in the follow-up period, i.e. the child
was diagnosed at any time point within the first 3 years
of life.
External standard
The GP occupies a central position in the Danish health
care service and the GP records are considered a reliable
external data source. Citizens are signed up with a GP of
his own choice and are allowed to change only once a
year. The GP is the patients’ primary contact with the
health service and act as "gate keeper" to secondary care
specialists. The GP keeps a record on every patient. A
personal identification number is assigned to every
Danish citizen linking all health care utilizations to the
patient. If a patient seeks other medical health care, such
as outpatient clinic, emergency room and hospital, a dis-
charge summary is sent to the GP. Consequently no
patients are treated for an illness without automatic no-
tification of the GP, and any illness severe enough to
cause medical attention, even by phone, is registered by
the GP. Prescription rules in Denmark are strict and
only very few drugs can be bought over the counter
without doctor’s prescription, which excludes patients
from use of any antibiotics or anti-asthmatics without
prescription automatically recorded by the GP.
The family practitioner (GP) of every COPSAC child
was identified in the national health registry. Written
informed consent to retrieve information from other
health care sources, including the GP, was obtained from
both parents/legal guardians. The GP of children who
completed three study years was requested by mail to
send a copy of his record from the child’s first three
years of life. When the records were returned they were
reviewed by a trained senior medical student and com-
pared with COPSAC database information. The same
person reviewed all the records. When an event was cap-
tured by the GP but not by COPSAC, it was consideredas a missed event and was registered in a separate data
sheet by ICD10 code and dated. Sometimes dates of the
same type of event differed between COPSAC and GP
records. In such cases a time span of four weeks be-
tween the registered start dates was allowed.
Socioeconomics
As a proxy for socioeconomic status information on
household income, educational level and occupational
status of the mother was obtained at the one-year-visit.
Household income was classified into three groups: In-
come below average (<400.000 DKR), around average
(400.000 – 600.000 DKR) and above average (>600.000
DKR) [8]. The highest level of completed education was
divided into four categories: elementary school, college,
medium and university education. Occupational status
was described in four groups; professionals, non-profes-
sionals, unemployed and student; based on DISCO clas-
sification, a national statistic used by the Danish
National Statistic Agency (www.dst.dk).
Statistical analysis
The total number of medical events for a child (N) was
considered as the sum of events registered by COPSAC
(n) plus the additional missed events found in the GP
record. The completeness of COPSAC information was
estimated as the number of medical events recorded by
COPSAC (n) as a percentage of the total number of
medical events (N).
Completeness was estimated using a GEE model with
the logit link function taking into account the child vari-
ation. P-values corresponded to score tests. Confidence
intervals of sensitivities were estimated on a logit scale,
back-transformed and presented in brackets. Analyses
were done using PROC GENMOD in SAS 9.1.
Results
The first three years of longitudinal data collection was
completed by 350 children. 327 (93%) GPs responded to
the request of a copy of the child’s record. Of the
returned records 67 did not contain sufficient data for
the entire study period: In 65 cases the families had
moved from one city to another within the first 3 years
of life, and the new GP did not return information from
the former. In two cases the records were handwritten
and unreadable. The final population for this study was
therefore 260 children. 227 children (87%) attended all
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two visits and one child (0.3%) missed three visits.
For the 260 children a total of 6134 medical events
were recorded in the COPSAC database. In 586 cases a
medical event was registered by the GP but not by
COPSAC.
Table 1 displays the completeness of the groups. The
overall completeness including all the medical events
was 0.91 [0.90;0.92)]. Completeness for the atopic dis-
eases alone was 100%. Furthermore, there were no
wheezy episodes registered by the GP that was not
recorded in the diary or subsequently reported at the
interview, indicating high awareness about project par-
ticipation among both parents and doctors.
The completeness differed significantly (p < 0.0001)
between the four remaining disease groups.
Table 2 displays the relationship between completeness
and child’s asthma and socioeconomic status. The over-
all completeness was not associated with either child’s
asthma (p=0.27), mother’s education (p=0.19) or
mother’s occupation (p=0.28). The association with
household income was borderline significant (p=0.06)
with the completeness highest for the high income
group (0.93 [0.91;0.94]) and lowest for the low income
group (0.89 [0.86;0.91]) compared to the average income
group (0.91 [0.90;0.93]). We also looked at the relation-
ship between completeness within the five disease
groups and asthma and socioeconomic status and found
no significant associations.Table 2 Completeness on overall illness in subgroups
Completeness
Child's asthma status p = 0.2698
With asthma (48) 0.91 [0.90,0.92]
Without asthma (212) 0.90 [0.87,0.92]
Household income p = 0.0589
High (65) 0.93 [0.91,0.94]
Medium (125) 0.91 [0.90,0.93]
Low (69) 0.89 [0.86,0.91]
Mother's education p = 0.1937
Elementary (103) 0.90 [0.87,0.91]
College (62) 0.92 [0.90,0.94]
Medium (64) 0.92 [0.90,0.94]
University (31) 0.93 [0.89,0.95]
Mother's employment p = 0.2842
Professional (114) 0.92 [0.90,0.94]
Non-professional (96) 0.91 [0.89,0.92]
Unemployed (24) 0.88 [0.82,0.92]
Student (26) 0.91 [0.87,0.94]
Number of patients in each group in parenthesis, 95% Confidence intervals in
brackets.Discussion
Main findings
Doctor’s interviews at six-monthly clinic visits on child’s
illness and symptoms supported by daily diary cards on
lung symptoms provided 100% completeness to the main
objectives of the study, the atopic diseases. Furthermore
the current study revealed completeness above 90% to
other respiratory and skin related illness and childhood
infections. Other illnesses were only captured with a
lower completeness around 77%. We saw an insignifi-
cant trend of better completeness in families from
higher social status, but no influence from child’s asthma
status.
Strengths and limitations
The strength of our data also relates to the close longitu-
dinal surveillance at the COPSAC clinical research unit.
The study is a single-centre study with six-monthly
assessments by experienced study-doctors examining
and taking clinical history based on standard operating
procedures supported by diary cards on atopy-related
symptoms. This assures consistency in procedures, defi-
nitions of conditions and data capture methods and re-
duce risk of misclassification. Atopic disorders such as
recurrent wheeze, asthma and atopic dermatitis in young
children display significant between-observer variation
[16-18]. The risk of misclassification is important par-
ticularly in young children with respiratory and skin dis-
orders because there is gross inconsistency among
doctors in their diagnostic and treatment practice,
reflecting little consensus on definition and best
practices.
It is a strength of our study is that we have provided
an external reference to validate symptom history, but
this choice can be debated. Previous reports have
indicated that morbidity recorded by GP is a reliable
estimate of community morbidity [19,20], and inter-
observer differences have revealed satisfactory agree-
ments between GPs around 80% [21,22]. Unfortunately
GP records are only kept by the GP personally. So far
there is no central registration of GP diagnose coding or
link to a national database. The gate keeper function of
the GP and the automatic notification of all health care
contacts make the GP record a very reliable source of in-
formation on health care interactions. The fact that
health care is free to all Danish citizens minimizes socio-
economic status as a significant confounder of contacts
to the health care system.
Nevertheless, the study is limited by the fact that the
GP record can only give information on illness where
parents considered medical attention necessary. In fact,
it is known that a large proportion of childhood illness
resolves spontaneously and is not reported to the profes-
sional health care [23,24]. It is a further limitation that
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with the issue of under-reporting, i.e. sensitivity, but not
over-reporting, i.e. specificity. We only captured missed
diagnoses, but we cannot know the degree of over-
reporting of illness, which was previously reported as a
problem in interview surveys [3,25].
It is a limitation that our results relate only to inter-
views done six-monthly and do not permit us do draw
conclusions on interview studies with shorter or longer
intervals. We allowed a time span of 4 weeks between
family practitioner and COPSAC registration of events.
This choice is debatable since several events in either
source could occur within this period and potentially
lead to an underestimation of unreported events.
It is a limitation that we only received GP records with
full follow up from 260 out of 350 children (74%). How-
ever, it can be argued that the individual GP’s willingness
to provide COPSAC with sufficient data can be consid-
ered independent of the parent’s study compliance.
Socioeconomic status was determined at one year of
age, but household income, educational and occupa-
tional status are dynamic and can change over the
course of a study. However this study is carried out in a
relatively short period of time, so we consider status at
one year of age as a reasonable estimate for the entire
study period. Another limitation in measuring socioeco-
nomic status is that only education and occupation of
the mother, but not the father was included. We used
univariate analysis; this choice can also be questioned,
since education and income are likely to be correlated
and interactive effects can be missed by this procedure,
although consensus on this matter is not clear [26].
The generalizability of our conclusions to a general
population can be questioned because of the high-risk
nature of the population. Subgroup analysis showed that
the completeness of symptom history was independent
of the child’s asthma symptoms, but the fact that all
mothers had a history of asthma is likely to increase
their awareness of symptoms associated with lung
symptoms.
Interpretation
This study primarily addresses the validity of COPSAC
data. It also addresses the reliability of information on
child health collected by parental interviews. The results
can be beneficial to researchers working with cohort
studies investigating pediatric public health, particularly
atopic diseases. Data on illness are not perfect, but ac-
ceptable. The majority of studies on general illness in
early childhood in Denmark are either retrospective [27],
cross-sectional [28] or follow children for a shorter
period of time [23,29], and little is known about the val-
idity of such data. We would expect them to be less
accurate without the close follow-up that the clinicalcohort study provides, but further studies on this subject
would be of great value.
Parents of children with many symptoms may be sus-
pected to be more compliant with the project than the
parents of children without symptoms, which could
introduce confounding to further analysis. However,
subgroup analysis showed sensitivity was independent
on the child’s asthma.
Data on non-infectious events are not appropriate for
further analysis due to the low completeness. Compari-
son of medical events with low sensitivities to those with
higher suggests that understanding of the concept of ill-
ness influences reporting (Table 2). When asked about
illness in childhood the parents preferentially report in-
fectious diseases or diseases with similar symptoms, even
though the interviews specifically invite any kind of ill-
ness. Participating in a study focused on asthma, eczema
and allergy, parents may consider common events such
as conjunctivitis and thrush as everyday complaints not
severe enough to be considered as illness, and non-
infectious events such as fractures, burns and wounds
are not considered relevant for reporting.
We saw an insignificant trend of better completeness
in families from higher social status. Although insignifi-
cant in this study, it may be prudent to consider this as
a potential confounder.
Conclusion
Clinical interviews of parents at six-monthly intervals
shows complete sensitivity to the study objectives of
child’s atopic disorders and very high sensitivity to other
respiratory and skin disorders with no important influ-
ence from socioeconomic status or concurrent asthma.
Our findings support the completeness of prospective
doctor’s interviews at the clinic supported by diaries
when assessing childhood health and symptoms related
to atopic disease.
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